0001231919-26-001065.txt : 20260825 0001231919-26-001065.hdr.sgml : 20260825 20260825121538 ACCESSION NUMBER: 0001231919-26-001065 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260825 DATE AS OF CHANGE: 20260825 EFFECTIVENESS DATE: 20260825 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Axiom Therapeutics Inc. CENTRAL INDEX KEY: 0002147556 ORGANIZATION NAME: EIN: 994309476 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-595274 FILM NUMBER: 261313879 BUSINESS ADDRESS: STREET 1: 2093 PHILADELPHIA PIKE #1369 CITY: CLAYMONT STATE: DE ZIP: 19703 BUSINESS PHONE: 513-874-5502 MAIL ADDRESS: STREET 1: 2093 PHILADELPHIA PIKE #1369 CITY: CLAYMONT STATE: DE ZIP: 19703 D 1 primary_doc.xml X0708 D LIVE 0002147556 Axiom Therapeutics Inc. 2093 PHILADELPHIA PIKE #1369 CLAYMONT DE DELAWARE 19703 513-874-5502 DELAWARE None None Corporation true 2024 Ryan John Geiser 2093 Philadelphia Pike #1369 Claymont DE DELAWARE 19703 Executive Officer Director Promoter Christopher Patrick Hamilton Haggard 2093 Philadelphia Pike #1369 Claymont DE DELAWARE 19703 Executive Officer Director Promoter Sofia Dahoune 2093 Philadelphia Pike #1369 Claymont DE DELAWARE 19703 Director Other Technology Decline to Disclose 06b false 2026-08-11 false true false 0 12287219 12287219 0 Total offering amount includes $2,287,220.00 which was previously received by the issuer in connection with the sale of convertible securities. false 31 0 0 0 false Axiom Therapeutics Inc. /s/ Ryan Geiser Ryan Geiser Chief Executive Officer 2026-08-25